Monjuvi 200 mg lyophilized powder for injection Images
Generic Name: tafasitamab
This medication has been identified as Monjuvi 200 mg lyophilized powder for injection and is used for Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma. It belongs to the drug class CD19 monoclonal antibodies and is not a controlled substance.
Images of medication
Monjuvi
- Generic Name
- tafasitamab
- Strength
- 200 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- CD19 monoclonal antibodies
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- MorphoSys US Inc.
- National Drug Code (NDC)
- 73535-0208
See also:
More about Monjuvi (tafasitamab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD19 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.